학술논문
Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups.
Document Type
article
Author
Shah, Urvi; Moshier, Erin; Derkach, Andriy; Huang, Yuanhui; Mailankody, Sham; Tan, Carlyn; Maclachlan, Kylee; Hultcrantz, Malin; Korde, Neha; Hassoun, Hani; Thibaud, Santiago; Sanchez, Larysa; Rodriguez, Cesar; Richard, Shambavi; Richter, Joshua; Rossi, Adriana; Cho, Hearn; Lesokhin, Alexander; Usmani, Saad; Jagannath, Sundar; Parekh, Samir; Gallagher, Emily; Chari, Ajai
Source
Blood Advances. 8(1)
Subject
Language
Abstract
Multiple myeloma (MM) is twice as common in Black individuals compared with in White individuals, and diabetes mellitus (DM) disproportionately affects Black patients. Although numerous studies have shown a correlation between DM and MM, this has not been studied in the context of race and in vivo mechanisms. We conducted a retrospective clinical study of 5383 patients with MM of which 15% had DM (White, 12% and Black, 25%). Multivariable Cox models showed reduced overall survival (OS) for patients with DM (hazard ratio, 1.27; 95% confidence interval, 1.11-1.47; P < .001). This appeared to be driven by a marked difference in OS between White patients with and without DM but not in Black patients. In contrast, obesity was associated with better OS in Black patients but not in White patients. To complement this analysis, we assessed MM growth in a genetically engineered immunocompromised nonobese diabetic (Rag1-/-/muscle creatinine kinase promoter expression of a human IGF1R [M] with a lysine [K] to arginine [R] point mutation) mouse model to evaluate the mechanisms linking DM and MM. MM.1S xenografts grew in more Rag1-/-/MKR mice and grew more rapidly in the Rag1-/-/MKR mice compared with in controls. Western blot analysis found that MM1.S xenografts from Rag1-/-/MKR mice had higher phosphorylated S6 ribosomal protein (Ser235/236) levels, indicating greater activation of the mammalian target of rapamycin pathway. Our study is, to our knowledge, the first to evaluate racial differences in DM prevalence and survival in MM, as well as the effect of DM on tumor growth in mouse models. Our results suggest that DM may contribute to the higher incidence of MM in Black patients; and to improve survival in MM, DM management cannot be ignored.